FDA Expands Indication for Trelegy Ellipta in COPD FDA Expands Indication for Trelegy Ellipta in COPD

The once-daily, single inhaler triple therapy is now indicated for a broader population of patients with COPD.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news